Librería: Better World Books, Mishawaka, IN, Estados Unidos de America
EUR 6,56
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Very Good. Former library copy. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Librería: Better World Books: West, Reno, NV, Estados Unidos de America
EUR 6,56
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Good. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Librería: Bellwetherbooks, McKeesport, PA, Estados Unidos de America
EUR 3,13
Cantidad disponible: 7 disponibles
Añadir al carritohardcover. Condición: Fine. LIKE NEW!!! Has a red or black remainder mark on bottom/exterior edge of pages.
Librería: ThriftBooks-Atlanta, AUSTELL, GA, Estados Unidos de America
EUR 6,58
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: Good. No Jacket. Former library book; Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.
Librería: ThriftBooks-Atlanta, AUSTELL, GA, Estados Unidos de America
EUR 6,58
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: Very Good. No Jacket. Former library book; May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Idioma: Inglés
Publicado por Pegasus Books April 2021, 2021
ISBN 10: 1643136801 ISBN 13: 9781643136806
Librería: Isle of Books, Bozeman, MT, Estados Unidos de America
EUR 11,30
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: Very Good.
Librería: HPB Inc., Dallas, TX, Estados Unidos de America
EUR 8,19
Cantidad disponible: 1 disponibles
Añadir al carritohardcover. Condición: Very Good. Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority!
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 19,12
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
EUR 21,43
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread copy in mint condition.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 19,21
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New.
EUR 21,51
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Brand New.
Idioma: Inglés
Publicado por Avon, New York, NY, U.S.A., 1993
ISBN 10: 0380768534 ISBN 13: 9780380768530
Librería: Mirror Image Book, Sacramento, CA, Estados Unidos de America
Original o primera edición
EUR 17,35
Cantidad disponible: 1 disponibles
Añadir al carritoSoft cover. Condición: Near New. Weiman, Jon (cover) Ilustrador. First Edition. A Avon time travel paperback Romance. First printing 3/93 , in Near New condition with light shelf wear, Library seal embossed on 1st page. slight aging. WRAPPED IN PLASTIC BAG TO PROTECT CONDITION OF BOOK.*.CALIFORNIA RESIDENTS MUST INCLUDE SALES TAX.*We have other titles in this genre in stock and give discounts in shipping on additional books sent in the same package, please contact us for more info.**.Summary - .FOR ALL TIME - Lori Copeland - With the aid of Gypsy Magic, a beautiful contemporary woman is transported back to the 19th-Century California - where her bold and perilous love for a daring Mexican bandito will turn the tides of destiny. TIMESWEPT LOVE - Catherine Creel - After being enchanted by the 400-year-old portrait of a handsome Scottish lord, Elizabeth MacKenzie awakens to find herself in the arms of the man of her dreams - and in the throes of a glorious passio that threatens to devastate two noble warring houses. DESTINY'S SPELL - Kay McMahon - Fascinated by tragic tale of two sisters, a lonely professor is whisked back in time to the French Revolution - where only his courage and his love can save an innocent beauty from the guillotine.EDEN'S GATE - Bobbi Smith - A dedicated student of Soutern history, lovely Kacie is miraculously dispatched to a time of slavery and injustice - to prevent the catastrophe she knows is awaiting the dashing abolition who has captured her heart.
EUR 23,62
Cantidad disponible: 10 disponibles
Añadir al carritoHardback. Condición: New. From "pharma bros" to everday household budgets, just how did the pharmaceutical industry betray its own history-and how can it return to its tradition of care?It's an unfortunate and life-threatening fact: one in five Americans has skipped vital prescriptions simply because of the cost. These choices are being made even though we have reached a point in the conveyance of medical options where cancers can be cured and sight restored for those blinded by rare genetic disorders. How, in this time of such advancements, did we reach a point, where people cannot afford the very things that could save their lives? As the COVID-19 global pandemic has pointed out, we need the leadership of scientists, researchers, public health officials and lawmakers alike to guide us through not only in times of a global health crisis, but also during far more mundane times. For the first time in decades, people from all walks of life face the same need for medicine. It is time to discuss the tough questions about drug pricing in an open, honest and, hopefully, transparent manner. But first we must understand how we, as a society, got here. Medicines are arguably the most highly regulated-and cost-inflated-products in the United States. The discovery, development, manufacturing and distribution of medicines is carried out by an ever more complex and crowded set of industries, each playing a part in a larger "pharmaceutical enterprise" seeking to maximize profits. But this was not always the case. The Price of Health is the reveals the story of how the pharmaceutical enterprise took shape and led to the present crisis. The reputation of the pharmaceutical industry is suffering from self-inflicted wounds and its continued viability, indeed survival, is increasingly questioned. Yet the drug makers do not shoulder all the blame or responsibility for the current price crisis. Deeply researched, The Price of Health gives us hope as to how we can still right the ship, even amidst the roiling storm of a global pandemic. How have medicines have been made and distributed to consumers throughout the years? What sea of changes that have contributed to rising costs? Some individuals, actions, and systems will be familiar, others may surprise. Yet the combined implications of these actions for will be surprising and at times shocking to both industry professionals and average Americans alike. Like so much else in human history, the history of the pharmaceutical enterprise is populated mostly by well-intended and even noble individuals and organizations. Each contributed to the formation or maintenance of structures meant to improve the quality and quantity of life through the development and distribution of medicines. And yet systems originally created to do good have often been subverted in ways contrary to the motivations of their creators. Only by understanding this disconnect can we better tackle the underlying problems of the industry head on, preventing foreseeable, and.
EUR 28,18
Cantidad disponible: 1 disponibles
Añadir al carritoHardback. Condición: New. From "pharma bros" to everday household budgets, just how did the pharmaceutical industry betray its own history-and how can it return to its tradition of care?It's an unfortunate and life-threatening fact: one in five Americans has skipped vital prescriptions simply because of the cost. These choices are being made even though we have reached a point in the conveyance of medical options where cancers can be cured and sight restored for those blinded by rare genetic disorders. How, in this time of such advancements, did we reach a point, where people cannot afford the very things that could save their lives? As the COVID-19 global pandemic has pointed out, we need the leadership of scientists, researchers, public health officials and lawmakers alike to guide us through not only in times of a global health crisis, but also during far more mundane times. For the first time in decades, people from all walks of life face the same need for medicine. It is time to discuss the tough questions about drug pricing in an open, honest and, hopefully, transparent manner. But first we must understand how we, as a society, got here. Medicines are arguably the most highly regulated-and cost-inflated-products in the United States. The discovery, development, manufacturing and distribution of medicines is carried out by an ever more complex and crowded set of industries, each playing a part in a larger "pharmaceutical enterprise" seeking to maximize profits. But this was not always the case. The Price of Health is the reveals the story of how the pharmaceutical enterprise took shape and led to the present crisis. The reputation of the pharmaceutical industry is suffering from self-inflicted wounds and its continued viability, indeed survival, is increasingly questioned. Yet the drug makers do not shoulder all the blame or responsibility for the current price crisis. Deeply researched, The Price of Health gives us hope as to how we can still right the ship, even amidst the roiling storm of a global pandemic. How have medicines have been made and distributed to consumers throughout the years? What sea of changes that have contributed to rising costs? Some individuals, actions, and systems will be familiar, others may surprise. Yet the combined implications of these actions for will be surprising and at times shocking to both industry professionals and average Americans alike. Like so much else in human history, the history of the pharmaceutical enterprise is populated mostly by well-intended and even noble individuals and organizations. Each contributed to the formation or maintenance of structures meant to improve the quality and quantity of life through the development and distribution of medicines. And yet systems originally created to do good have often been subverted in ways contrary to the motivations of their creators. Only by understanding this disconnect can we better tackle the underlying problems of the industry head on, preventing foreseeable, and.
EUR 22,25
Cantidad disponible: 1 disponibles
Añadir al carritoHRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Idioma: Inglés
Publicado por Pegasus Books 2021-05-13, 2021
ISBN 10: 1643136801 ISBN 13: 9781643136806
Librería: Chiron Media, Wallingford, Reino Unido
EUR 19,39
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: New.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 23,02
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New. In.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 20,18
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 22,44
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
EUR 25,13
Cantidad disponible: 10 disponibles
Añadir al carritoHardback. Condición: New. From "pharma bros" to everday household budgets, just how did the pharmaceutical industry betray its own history-and how can it return to its tradition of care?It's an unfortunate and life-threatening fact: one in five Americans has skipped vital prescriptions simply because of the cost. These choices are being made even though we have reached a point in the conveyance of medical options where cancers can be cured and sight restored for those blinded by rare genetic disorders. How, in this time of such advancements, did we reach a point, where people cannot afford the very things that could save their lives? As the COVID-19 global pandemic has pointed out, we need the leadership of scientists, researchers, public health officials and lawmakers alike to guide us through not only in times of a global health crisis, but also during far more mundane times. For the first time in decades, people from all walks of life face the same need for medicine. It is time to discuss the tough questions about drug pricing in an open, honest and, hopefully, transparent manner. But first we must understand how we, as a society, got here. Medicines are arguably the most highly regulated-and cost-inflated-products in the United States. The discovery, development, manufacturing and distribution of medicines is carried out by an ever more complex and crowded set of industries, each playing a part in a larger "pharmaceutical enterprise" seeking to maximize profits. But this was not always the case. The Price of Health is the reveals the story of how the pharmaceutical enterprise took shape and led to the present crisis. The reputation of the pharmaceutical industry is suffering from self-inflicted wounds and its continued viability, indeed survival, is increasingly questioned. Yet the drug makers do not shoulder all the blame or responsibility for the current price crisis. Deeply researched, The Price of Health gives us hope as to how we can still right the ship, even amidst the roiling storm of a global pandemic. How have medicines have been made and distributed to consumers throughout the years? What sea of changes that have contributed to rising costs? Some individuals, actions, and systems will be familiar, others may surprise. Yet the combined implications of these actions for will be surprising and at times shocking to both industry professionals and average Americans alike. Like so much else in human history, the history of the pharmaceutical enterprise is populated mostly by well-intended and even noble individuals and organizations. Each contributed to the formation or maintenance of structures meant to improve the quality and quantity of life through the development and distribution of medicines. And yet systems originally created to do good have often been subverted in ways contrary to the motivations of their creators. Only by understanding this disconnect can we better tackle the underlying problems of the industry head on, preventing foreseeable, and.
Librería: moluna, Greven, Alemania
EUR 27,86
Cantidad disponible: 1 disponibles
Añadir al carritoGebunden. Condición: New. From pharma bros to everday household budgets, just how did the pharmaceutical industry betray its own history-and how can it return to its tradition of care?Über den Autor Michael Kinch is a professor at Washin.
Idioma: Inglés
Publicado por Pegasus Books Jun 2021, 2021
ISBN 10: 1643136801 ISBN 13: 9781643136806
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 27,83
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. Neuware - From 'pharma bros' to everday household budgets, just how did the pharmaceutical industry betray its own historyand how can it return to its tradition of care.
EUR 25,28
Cantidad disponible: 1 disponibles
Añadir al carritoHardback. Condición: New. From "pharma bros" to everday household budgets, just how did the pharmaceutical industry betray its own history-and how can it return to its tradition of care?It's an unfortunate and life-threatening fact: one in five Americans has skipped vital prescriptions simply because of the cost. These choices are being made even though we have reached a point in the conveyance of medical options where cancers can be cured and sight restored for those blinded by rare genetic disorders. How, in this time of such advancements, did we reach a point, where people cannot afford the very things that could save their lives? As the COVID-19 global pandemic has pointed out, we need the leadership of scientists, researchers, public health officials and lawmakers alike to guide us through not only in times of a global health crisis, but also during far more mundane times. For the first time in decades, people from all walks of life face the same need for medicine. It is time to discuss the tough questions about drug pricing in an open, honest and, hopefully, transparent manner. But first we must understand how we, as a society, got here. Medicines are arguably the most highly regulated-and cost-inflated-products in the United States. The discovery, development, manufacturing and distribution of medicines is carried out by an ever more complex and crowded set of industries, each playing a part in a larger "pharmaceutical enterprise" seeking to maximize profits. But this was not always the case. The Price of Health is the reveals the story of how the pharmaceutical enterprise took shape and led to the present crisis. The reputation of the pharmaceutical industry is suffering from self-inflicted wounds and its continued viability, indeed survival, is increasingly questioned. Yet the drug makers do not shoulder all the blame or responsibility for the current price crisis. Deeply researched, The Price of Health gives us hope as to how we can still right the ship, even amidst the roiling storm of a global pandemic. How have medicines have been made and distributed to consumers throughout the years? What sea of changes that have contributed to rising costs? Some individuals, actions, and systems will be familiar, others may surprise. Yet the combined implications of these actions for will be surprising and at times shocking to both industry professionals and average Americans alike. Like so much else in human history, the history of the pharmaceutical enterprise is populated mostly by well-intended and even noble individuals and organizations. Each contributed to the formation or maintenance of structures meant to improve the quality and quantity of life through the development and distribution of medicines. And yet systems originally created to do good have often been subverted in ways contrary to the motivations of their creators. Only by understanding this disconnect can we better tackle the underlying problems of the industry head on, preventing foreseeable, and.